Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

December 17, 2013

Primary Completion Date

November 19, 2015

Study Completion Date

November 19, 2015

Conditions
Age-related Macular DegenerationChoroidal Neovascularization
Interventions
DRUG

Ranibizumab 0.5mg

0.5 mg ranibizumab (intravitreal injections) prefilled syringe)

DRUG

Ranibizumab 0.5mg

0.5 mg ranibizumab (intravitreal injections) prefilled syringe)

Trial Locations (91)

1000

Novartis Investigative Site, Ljubljana

1007

Novartis Investigative Site, Lausanne

1076

Novartis Investigative Site, Budapest

1083

Novartis Investigative Site, Budapest

1106

Novartis Investigative Site, Budapest

1133

Novartis Investigative Site, Budapest

1145

Novartis Investigative Site, Budapest

1340

Novartis Investigative Site, Ottignies

2020

Novartis Investigative Site, Antwerp

2600

Novartis Investigative Site, Glostrup Municipality

3010

Novartis Investigative Site, Bern

3012

Novartis Investigative Site, Bern

4000

Novartis Investigative Site, Roskilde

4012

Novartis Investigative Site, Debrecen

7624

Novartis Investigative Site, Pécs

8063

Novartis Investigative Site, Zurich

8900

Novartis Investigative Site, Zalaegerszeg

9620

Novartis Investigative Site, Zottegem

10000

Novartis Investigative Site, Zagreb

13620

Novartis Investigative Site, Seongnam-si

20100

Novartis Investigative Site, Milan

20132

Novartis Investigative Site, Milan

30625

Novartis Investigative Site, Hanover

33012

Novartis Investigative Site, Oviedo

33100

Novartis Investigative Site, Udine

35128

Novartis Investigative Site, Padua

37075

Novartis Investigative Site, Göttingen

39120

Novartis Investigative Site, Magdeburg

47011

Novartis Investigative Site, Valladolid

48145

Novartis Investigative Site, Münster

48149

Novartis Investigative Site, Münster

48683

Novartis Investigative Site, Ahaus

49100

Novartis Investigative Site, Petah Tikva

49241

Novartis Investigative Site, Busan

50009

Novartis Investigative Site, Zaragoza

50134

Novartis Investigative Site, Florence

50935

Novartis Investigative Site, Cologne

53721

Novartis Investigative Site, Siegburg

56124

Novartis Investigative Site, Pisa

64297

Novartis Investigative Site, Darmstadt

66280

Novartis Investigative Site, Sulzbach

67063

Novartis Investigative Site, Ludwigshafen

70174

Novartis Investigative Site, Stuttgart

76100

Novartis Investigative Site, Rehovot

76199

Novartis Investigative Site, Karlsruhe

82606

Novartis Investigative Site, Bratislava

86156

Novartis Investigative Site, Augsburg

94001

Novartis Investigative Site, Nové Zámky

97517

Novartis Investigative Site, Banská Bystrica

119021

Novartis Investigative Site, Moscow

127486

Novartis Investigative Site, Moscow

420012

Novartis Investigative Site, Kazan'

443068

Novartis Investigative Site, Samara

560010

Novartis Investigative Site, Bangalore

630071

Novartis Investigative Site, Novosibirsk

695035

Novartis Investigative Site, Vanchiyoor

3525408

Novartis Investigative Site, Haifa

6423906

Novartis Investigative Site, Tel Aviv

7650018

Novartis Investigative Site, Santiago

9112001

Novartis Investigative Site, Jerusalem

Unknown

Novartis Investigative Site, Cairo

Novartis Investigative Site, Cairo

04103

Novartis Investigative Site, Leipzig

09113

Novartis Investigative Site, Chemnitz

H-1115

Novartis Investigative Site, Budapest

H-6725

Novartis Investigative Site, Szeged

600 006

Novartis Investigative Site, Chennai

00198

Novartis Investigative Site, Roma

07100

Novartis Investigative Site, Sassari

3000-354

Novartis Investigative Site, Coimbra

3030-163

Novartis Investigative Site, Coimbra

1150-314

Novartis Investigative Site, Lisbon

4099-001

Novartis Investigative Site, Porto

2600-009

Novartis Investigative Site, Vila Franca de Xira

05845

Novartis Investigative Site, Poprad

01207

Novartis Investigative Site, Žilina

03080

Novartis Investigative Site, Seoul

06591

Novartis Investigative Site, Seoul

08025

Novartis Investigative Site, Barcelona

08022

Novartis Investigative Site, Barcelona

08190

Novartis Investigative Site, Sant Cugat del Vallès

06490

Novartis Investigative Site, Ankara

06100

Novartis Investigative Site, Ankara

UB8 3NN

Novartis Investigative Site, Uxbridge

GU16 7UJ

Novartis Investigative Site, Frimley

BT12 6BA

Novartis Investigative Site, Belfast

BS1 2LX

Novartis Investigative Site, Bristol

GU2 5XX

Novartis Investigative Site, Guildford, Surrey

EC1V 2PD

Novartis Investigative Site, London

M13 9WL

Novartis Investigative Site, Manchester

SR2 9HP

Novartis Investigative Site, Sunderland

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY